(Q48674846)

14 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT). (English)

1 reference

14 February 2018

0 references

1 reference

ChEBI release 2020-05-28

Fadel S Alyaqoub

1

1 reference

14 February 2018

Lianhui Tao

2

1 reference

14 February 2018

Paula M Kramer

3

1 reference

14 February 2018

Vernon E Steele

4

1 reference

14 February 2018

Ronald A Lubet

5

1 reference

14 February 2018

William T Gunning

6

1 reference

14 February 2018

Michael A Pereira

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

2 August 2006

1 reference

14 February 2018

published in

Carcinogenesis

1 reference

14 February 2018

volume

28

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

124-129

1 reference

14 February 2018

Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

DNA methylation in cancer: too much, but also too little

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

The role of budesonide in adults and children with mild-to-moderate persistent asthma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Effect of increased glucocorticoid responsiveness in transformed mouse lung cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Farnesyltransferase inhibitors: potential role in the treatment of cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

New targets for therapy in breast cancer: farnesyltransferase inhibitors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Farnesyltransferase inhibitors: promises and realities

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Effect of chemopreventive agents on separate stages of progression of benzo[ ]pyrene induced lung tumors in A/J mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Ras family signaling: therapeutic targeting

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Induction of Tumors in Mice by Genomic Hypomethylation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Tipifarnib: farnesyl transferase inhibition at a crossroads

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1093/CARCIN/BGL136

Identifiers

DOI

10.1093/CARCIN/BGL136

1 reference

14 February 2018

1 reference

14 February 2018